CRT 2023
Atherosclerosis and Vulnerable Plaque
David Erlinge, MD, PhD (he/him/his)
Professor, Consultant Interventional Cardiology
Lund University
Lund, Sweden
Disclosure(s): Abbott Laboratories, Boston Scientific, Covidien, Janssen Pharmaceuticals, The Medicines Company, Sanofi-Aventis: Advisory Committee/Board Member (Ongoing); AstraZeneca: Clinical Trial Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bayer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BMS/Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Scientific Advisory Board (Ongoing)
Biljana Parapid, MD, PhD (she/her/hers)
Assistant Professor, Department of Medicine - Cardiology
Belgrade University School of Medicine
Belgrade, Serbia
No relationships to disclose
Allen J. Taylor, MD
Chairman of Cardiology
MedStar Heart and Vascular Institute
Washington, District of Columbia, United States
Disclosure(s): Amgen: Speakers' Bureau (Ongoing); Espirion: Speakers' Bureau (Ongoing)
Ron Waksman, MD, MSCAI
Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States
Disclosure information not submitted.